dnTGFβRIISTEAP2Metastatic castration-resistant prostate cancer (mCRPC)mCRPCchimeric antigen receptor (CAR) T cell therapy
…d (4) overcoming immunosuppression by armoring CAR T cells with dnTGFβRII. Bispecific secretion is restricted to NFAT-activated CAR T cel…